Fred Aslan
CIK: 0001909362
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Artiva Biotherapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (25 total)
- Nov 2, 2026ARTV
Artiva Biotherapeutics, Inc.
Sale(S)Direct62.2K shares at avg. $4.18$260K - Oct 6, 2026ARTV
Artiva Biotherapeutics, Inc.
Sale(S)Direct23.5K shares at avg. $7.20$169K - Oct 5, 2026ARTV
Artiva Biotherapeutics, Inc.
Sale(S)Direct61.7K shares at avg. $6.84$422K - Sep 15, 2026ARTV
Artiva Biotherapeutics, Inc.
Award(A)Direct110K shares- - Sep 10, 2026ARTV
Artiva Biotherapeutics, Inc.
Award(A)Direct45K shares- - Sep 8, 2026ARTV
Artiva Biotherapeutics, Inc.
Sale(S)Direct23.4K shares at avg. $10.92$256K - Sep 3, 2026ARTV
Artiva Biotherapeutics, Inc.
Sale(S)Direct61.9K shares at avg. $11.16$690K - May 19, 2026ARTV
Artiva Biotherapeutics, Inc.
Sale(S)Direct27.1K shares at avg. $9.01$244K - Feb 15, 2026ARTV
Artiva Biotherapeutics, Inc.
Award(A)Direct366.9K shares- - Feb 15, 2026ARTV
Artiva Biotherapeutics, Inc.
Tax Payment(F)Direct14.6K shares at avg. $4.00$58K - Dec 15, 2025ARTV
Artiva Biotherapeutics, Inc.
Sale(S)Direct3.2K shares at avg. $6.00$19K - Dec 12, 2025ARTV
Artiva Biotherapeutics, Inc.
Disposition(D)DirectEmployee Stock Option (Right to Buy)
51.5K shares- - Dec 12, 2025ARTV
Artiva Biotherapeutics, Inc.
Disposition(D)DirectEmployee Stock Option (Right to Buy)
26.5K shares- - Dec 12, 2025ARTV
Artiva Biotherapeutics, Inc.
Award(A)Direct869.1K shares- - Dec 12, 2025ARTV
Artiva Biotherapeutics, Inc.
Disposition(D)DirectEmployee Stock Option (Right to Buy)
114K shares- - Dec 12, 2025ARTV
Artiva Biotherapeutics, Inc.
Disposition(D)DirectEmployee Stock Option (Right to Buy)
100.6K shares- - Dec 12, 2025ARTV
Artiva Biotherapeutics, Inc.
Disposition(D)DirectEmployee Stock Option (Right to Buy)
257.3K shares- - Dec 12, 2025ARTV
Artiva Biotherapeutics, Inc.
Disposition(D)DirectEmployee Stock Option (Right to Buy)
319.3K shares- - Nov 17, 2025ARTV
Artiva Biotherapeutics, Inc.
Sale(S)Direct6.4K shares at avg. $3.38$22K - Nov 15, 2025ARTV
Artiva Biotherapeutics, Inc.
Tax Payment(F)Direct6.3K shares at avg. $3.25$21K - Oct 17, 2025ARTV
Artiva Biotherapeutics, Inc.
Sale(S)Direct25.5K shares at avg. $6.00$153K - Aug 15, 2025ARTV
Artiva Biotherapeutics, Inc.
Tax Payment(F)Direct4.5K shares at avg. $2.75$12K - Aug 15, 2025ARTV
Artiva Biotherapeutics, Inc.
Sale(S)Direct25.5K shares at avg. $2.73$70K - May 15, 2025ARTV
Artiva Biotherapeutics, Inc.
Tax Payment(F)Direct4.5K shares at avg. $2.13$10K - Mar 5, 2025ARTV
Artiva Biotherapeutics, Inc.
Award(A)Direct200K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Nov 2, 2026 | ARTV Artiva Biotherapeutics, Inc. | Sale(S) | 62,178 | $4.18 | $259,972 | Direct |
| Oct 6, 2026 | ARTV Artiva Biotherapeutics, Inc. | Sale(S) | 23,463 | $7.20 | $168,880 | Direct |
| Oct 5, 2026 | ARTV Artiva Biotherapeutics, Inc. | Sale(S) | 61,696 | $6.84 | $421,828 | Direct |
| Sep 15, 2026 | ARTV Artiva Biotherapeutics, Inc. | Award(A) | 110,000 | - | $0 | Direct |
| Sep 10, 2026 | ARTV Artiva Biotherapeutics, Inc. | Award(A) | 45,000 | - | $0 | Direct |
| Sep 8, 2026 | ARTV Artiva Biotherapeutics, Inc. | Sale(S) | 23,429 | $10.92 | $255,746 | Direct |
| Sep 3, 2026 | ARTV Artiva Biotherapeutics, Inc. | Sale(S) | 61,888 | $11.16 | $690,392 | Direct |
| May 19, 2026 | ARTV Artiva Biotherapeutics, Inc. | Sale(S) | 27,116 | $9.01 | $244,253 | Direct |
| Feb 15, 2026 | ARTV Artiva Biotherapeutics, Inc. | Award(A) | 366,850 | - | $0 | Direct |
| Feb 15, 2026 | ARTV Artiva Biotherapeutics, Inc. | Tax Payment(F) | 14,600 | $4.00 | $58,400 | Direct |
| Dec 15, 2025 | ARTV Artiva Biotherapeutics, Inc. | Sale(S) | 3,187 | $6.00 | $19,122 | Direct |
| Dec 12, 2025 | ARTV Artiva Biotherapeutics, Inc. | Disposition(D) Employee Stock Option (Right to Buy) | 51,463 | - | - | Direct |
| Dec 12, 2025 | ARTV Artiva Biotherapeutics, Inc. | Disposition(D) Employee Stock Option (Right to Buy) | 26,450 | - | - | Direct |
| Dec 12, 2025 | ARTV Artiva Biotherapeutics, Inc. | Award(A) | 869,136 | - | - | Direct |
| Dec 12, 2025 | ARTV Artiva Biotherapeutics, Inc. | Disposition(D) Employee Stock Option (Right to Buy) | 113,999 | - | - | Direct |
| Dec 12, 2025 | ARTV Artiva Biotherapeutics, Inc. | Disposition(D) Employee Stock Option (Right to Buy) | 100,577 | - | - | Direct |
| Dec 12, 2025 | ARTV Artiva Biotherapeutics, Inc. | Disposition(D) Employee Stock Option (Right to Buy) | 257,319 | - | - | Direct |
| Dec 12, 2025 | ARTV Artiva Biotherapeutics, Inc. | Disposition(D) Employee Stock Option (Right to Buy) | 319,331 | - | - | Direct |
| Nov 17, 2025 | ARTV Artiva Biotherapeutics, Inc. | Sale(S) | 6,375 | $3.38 | $21,522 | Direct |
| Nov 15, 2025 | ARTV Artiva Biotherapeutics, Inc. | Tax Payment(F) | 6,347 | $3.25 | $20,628 | Direct |
| Oct 17, 2025 | ARTV Artiva Biotherapeutics, Inc. | Sale(S) | 25,500 | $6.00 | $153,000 | Direct |
| Aug 15, 2025 | ARTV Artiva Biotherapeutics, Inc. | Tax Payment(F) | 4,472 | $2.75 | $12,298 | Direct |
| Aug 15, 2025 | ARTV Artiva Biotherapeutics, Inc. | Sale(S) | 25,500 | $2.73 | $69,579 | Direct |
| May 15, 2025 | ARTV Artiva Biotherapeutics, Inc. | Tax Payment(F) | 4,472 | $2.13 | $9,525 | Direct |
| Mar 5, 2025 | ARTV Artiva Biotherapeutics, Inc. | Award(A) | 200,000 | - | - | Direct |
1-25 of 25 transactions
About Aslan Fred
Aslan Fred (SEC CIK 0001909362) files insider reports with the SEC as Chief Executive Officer of Artiva Biotherapeutics, Inc. (ARTV).
Signal8 holds 15 ownership filings by Aslan Fred, all Form 4s, filed between Mar 7, 2025 and Nov 3, 2026. Those filings report 25 transactions, from Mar 5, 2025 to Nov 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Aslan Fred's filings is in SAN DIEGO, CA.
Recent filings by Aslan Fred
- Nov 2, 2026: Open-market sale of ARTV shares (Form 4, code S).
- Oct 6, 2026: Open-market sale of ARTV shares (Form 4, code S).
- Oct 5, 2026: Open-market sale of ARTV shares (Form 4, code S).
- Sep 15, 2026: Grant or award of ARTV shares (Form 4, code A).
- Sep 10, 2026: Grant or award of ARTV shares (Form 4, code A).
Other insiders filing for Artiva Biotherapeutics, Inc. (ARTV)
- Horan Christopher, Chief Tech Operations Officer
- Bush Jennifer, COO, CLO, Compliance Officer
- Banerjee Subhashis, Chief Medical Officer
- RA CAPITAL MANAGEMENT, L.P., Director
- Stoppel Laura, Director
- Sorg Elaine K., Director